AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 71 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $335,817 | -66.2% | 24,747 | -57.2% | 0.00% | -60.0% |
| Q2 2023 | $992,539 | -52.7% | 57,874 | -44.4% | 0.01% | -54.5% |
| Q1 2023 | $2,098,648 | -51.6% | 104,048 | -29.7% | 0.01% | -52.2% |
| Q4 2022 | $4,335,082 | +43.5% | 147,955 | -18.8% | 0.02% | +53.3% |
| Q3 2022 | $3,022,000 | +12.0% | 182,281 | +5.5% | 0.02% | +15.4% |
| Q2 2022 | $2,699,000 | -11.8% | 172,706 | +3.4% | 0.01% | +30.0% |
| Q1 2022 | $3,061,000 | +55.5% | 167,007 | 0.0% | 0.01% | +100.0% |
| Q4 2021 | $1,969,000 | – | 167,007 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |